Aptahem AB (publ)
APTA
Rank in Stocks
#33398
Aptahem AB (publ) is a clinical-stage biotechnology company dedicated to... Aptahem AB (publ) is a clinical-stage biotechnology company dedicated to creating aptamer-based pharmaceuticals aimed at treating acute, life-threatening medical conditions. Its flagship drug candidate, Apta-1, is currently in preclinical development, designed to reduce the mortality rate in sepsis patients by combating organ and tissue damage. The company has established partnerships with several academic institutions, notably through a consortium comprising Örebro University, Seattle Children's Research Institute, and University Health Network. Founded in 2014, Aptahem AB (publ) operates from its headquarters in Malmö, Sweden.
Share Price
$0.02219701
Last synced: 2026-11-05
Market Cap
$575.64K
Change (1 day)
6.90%
Change (1 year)
-80.00%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Aptahem AB (publ) (APTA)
Category
Healthcare
EPS for Aptahem AB (publ) (APTA)
EPS as of June 2026 TTM: $-0.03
According to Aptahem AB (publ)'s latest financial reports, its current EPS (TTM) is $-0.03. At the end of 2025 the company had an EPS of $-0.03, an increase over its 2024 EPS of $-0.06.
EPS history for Aptahem AB (publ) from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.03 | -5.67% |
| 2025 | $-0.03 | -46.33% |
| 2024 | $-0.06 | -86.45% |
| 2023 | $-0.46 | 14.42% |
| 2022 | $-0.40 | -80.65% |
| 2021 | $-2.09 | -38.64% |
| 2020 | $-3.40 | 19.37% |
| 2019 | $-2.85 | -72.30% |
| 2018 | $-10.28 | 102.29% |
| 2017 | $-5.08 | 16.64% |
| 2016 | $-4.36 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -55,435.69% |
US
|
|
| $-7.07 | 24,882.33% |
US
|
|
| $-5.29 | 18,592.58% |
AU
|
|
| $12.88 | -45,612.72% |
BE
|
|
| $21.56 | -76,283.75% |
NL
|
Questions about Aptahem AB (publ)'s earnings per share (EPS)
What is Aptahem AB (publ)'s earnings per share (EPS)?
Aptahem AB (publ)'s earnings per share (EPS) over the last twelve months is $-0.03, as of Jun 2026.
What was Aptahem AB (publ)'s earnings per share (EPS) in 2025?
In 2025, Aptahem AB (publ)'s earnings per share (EPS) was $-0.03, compared with $-0.06 in 2024.
How has Aptahem AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Aptahem AB (publ)'s earnings per share (EPS) was highest in 2025 ($-0.03) and lowest in 2020 ($-3.40).
How does Aptahem AB (publ)'s earnings per share (EPS) compare with similar companies?
Aptahem AB (publ)'s earnings per share (EPS) ($-0.03) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.